Literature DB >> 25766866

Increased cause-specific mortality in patients with mild and severe psoriasis: a population-based Swedish register study.

Axel Svedbom1, Johan Dalén, Carla Mamolo, Joseph C Cappelleri, Lotus Mallbris, Ingemar F Petersson, Mona Ståhle.   

Abstract

Several studies have shown excess risk for a number of comorbidities in patients with psoriasis compared with the general population, but data on cause-specific mortality in this patient population are limited. The aim of this study was to estimate the associations of psoriasis and 12 specific causes of death and all-cause mortality in patients with mild and severe psoriasis. The study was based on data from Swedish administrative registers and compared the risk of death in 39,074 patients with psoriasis with 154,775 sex-, age- and residency-matched referents using Cox proportional hazards models. In patients with mild and severe psoriasis, the strongest associations were observed for deaths due to kidney disease (hazard ratio [HR]=2.20, p < 0.01) and liver disease (HR = 4.26, p < 0.001), respectively. Whilst cardiovascular disease was the main driver of excess mortality in absolute terms, the risks for other causes of death were also substantially elevated in patients with psoriasis compared with matched referents.

Entities:  

Mesh:

Year:  2015        PMID: 25766866     DOI: 10.2340/00015555-2095

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  16 in total

1.  Response to 'Kidney disease in moderate-to-severe psoriasis: a critical appraisal'.

Authors:  J Wan; J M Gelfand
Journal:  Br J Dermatol       Date:  2016-02       Impact factor: 9.302

2.  Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by.

Authors:  George Martin; Bruce E Strober; Craig L Leonardi; Joel M Gelfand; Andrew Blauvelt; Arthur Kavanaugh; Linda Stein Gold; Brian Berman; Ted Rosen; Eggert Stockfleth
Journal:  J Clin Aesthet Dermatol       Date:  2016-09-01

3.  Objective Measures of Psoriasis Severity Predict Mortality: A Prospective Population-Based Cohort Study.

Authors:  Megan H Noe; Daniel B Shin; Marilyn T Wan; Joel M Gelfand
Journal:  J Invest Dermatol       Date:  2017-08-23       Impact factor: 8.551

Review 4.  The Psoriasis Decision Tree.

Authors:  George Monks; Ryan Rivera-Oyola; Mark Lebwohl
Journal:  J Clin Aesthet Dermatol       Date:  2021-04-01

5.  Psoriasis severity matters when dealing with all-cause mortality in psoriasis patients: a record linkage analysis in Northern Italy.

Authors:  Elena Pezzolo; Roberta Ciampichini; Simone Cazzaniga; Giuseppe Sampietro; Alberto Zucchi; Luigi Naldi
Journal:  Arch Dermatol Res       Date:  2020-07-05       Impact factor: 3.017

Review 6.  The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives.

Authors:  Steven R Feldman; Bernard Goffe; Gary Rice; Matthew Mitchell; Mandeep Kaur; Debbie Robertson; Debra Sierka; Jeffrey A Bourret; Tamara S Evans; Alice Gottlieb
Journal:  Am Health Drug Benefits       Date:  2016-12

7.  Psoriasis: The Poster Child for Bench-to-bedside Translational Medicine.

Authors:  Lotus Mallbris; Brian J Nickoloff
Journal:  J Clin Aesthet Dermatol       Date:  2015-07

Review 8.  Kidney disease and psoriasis: novel evidences beyond old concepts.

Authors:  Luca Visconti; Giuseppe Leonardi; Michele Buemi; Domenico Santoro; Valeria Cernaro; Carlo Alberto Ricciardi; Antonio Lacquaniti; Giuseppe Coppolino
Journal:  Clin Rheumatol       Date:  2015-11-28       Impact factor: 2.980

Review 9.  Psoriasis and comorbid diseases: Epidemiology.

Authors:  Junko Takeshita; Sungat Grewal; Sinéad M Langan; Nehal N Mehta; Alexis Ogdie; Abby S Van Voorhees; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2017-03       Impact factor: 11.527

10.  Alcohol-Related Mortality in Patients With Psoriasis: A Population-Based Cohort Study.

Authors:  Rosa Parisi; Roger T Webb; Matthew J Carr; Kieran J Moriarty; C Elise Kleyn; Christopher E M Griffiths; Darren M Ashcroft
Journal:  JAMA Dermatol       Date:  2017-12-01       Impact factor: 10.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.